Prevalence and clinical signs of inflammatory back pain in patients with skin psoriasis and axial involvement

Abstract

BACKGROUND: The incidence of psoriatic arthritis has been increasing in recent years. Moreover the number of severe cases resistant to standard therapy has been increasing as well and leading to a marked deterioration in the quality of life and early disability. There is a need to diagnose the disease at preclinical stages, as well as early therapy and secondary prevention. Therefore, the role of dermatologists in identifying predictors and risk factors for the development and severe course of psoriatic arthritis is increasing. Particularly severe forms of psoriatic arthritis are caused by axial manifestations, which are often clinically asymptomatic in early stage of psoriatic arthritis. Moreover, most often axial manifestations is diagnosed in patients with an already established diagnosis of psoriatic arthritis, and there is practically no data on the prevalence and clinical and instrumental characteristics of axial manifestations in patients with smooth skin psoriasis.

AIM: to assess the prevalence and clinical characteristic of axial manifestations in patients with skin psoriasis using questionnaires, scales and Аssessment of SpondyloArthritis International Society (ASAS) diagnostic criteria.

MATERIALS AND METHODS: The prospective study to assess the prevalence and clinical characteristiс of axial manifestations in patients with skin psoriasis.

RESULTS: The prevalence of axial manifestations in patients with skin psoriasis, according to ASAS criteria, was 36.1%. Early manifestations of axial lesions in patients with skin psoriasis are aching, nagging pain in the back (37.2%) or neck (22.1%), as well as a feeling of stiffness in the back (46.3%) or neck (38.9%). The main risk factors and predictors of the development of psoriatic arthritis were the long duration of skin psoriasis (more than 12 years), pain in any joints, swelling of the fingers, pain/stiffness in the neck, pain/stiffness in the back, pain in the joints at rest/night time, widespread (BSA >18 points), severe (PASI >13 points) process. Having back/neck pain at rest or at night increases the odds of developing inflammatory pain by 132 times and 10 times, respectively, and back/neck stiffness by 10 and 6 times, respectively. Increasing the age of onset of back/neck pain by 1 year increases the chances of developing axial lesions by 1.3 times.

CONCLUSION: There is the first study to identify clinical signs of inflammatory back pain in patient with axial manifestations at early stage of psoriatic arthritis and to determine the prevalence of inflammatory back pain in patients with skin psoriasis and without an established diagnosis of psoriatic arthritis. However, further study of methods for early diagnosis of axial manifestations and other forms of psoriatic arthritis is necessary to optimize treatment and improve the quality of life of patients.

Keywords

psoriasis / psoriatic arthritis / axial manifestations / inflammatory back pain / sacroiliitis / spondylitis

References

[1] Veale DJ, Fearon U. The pathogenesis of psoriatic arthritis. Lancet. 2018;391(10136):2273-2284. doi: 10.1016/S0140-6736(18)30830-4

[2] Veale D.J., Fearon U. The pathogenesis of psoriatic arthritis // Lancet. 2018. Vol. 391, N 10136. P. 2273-2284. doi: 10.1016/S0140-6736(18)30830-4

[3] Mishina OS, Korotaeva TV, Starodubov VI, Nasonov EL. Incidence of psoriatic arthritis in Russia: Trends at the present stage and prospects. Rheumatol Sci Pract. 2015;53(3):251-257. EDN: UIEIDL doi: 10.14412/1995-4484-2015-251-257

[4] Мишина О.С., Коротаева Т.В., Стародубов В.И., Насонов Е.Л. Заболеваемость псориатическим артритом в России: тенденции на современном этапе и перспективы // Научно-практическая ревматология. 2015. Т. 53, № 3. C. 251-257. EDN: UIEIDL doi: 10.14412/1995-4484-2015-251-257

[5] Tillett W, Charlton R, Nightingale A. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort. Rheumatology (Oxford). 2017;56(12):2109-2113. doi: 10.1093/rheumatology/kex323

[6] Tillett W., Charlton R., Nightingale A. Interval between onset of psoriasis and psoriatic arthritis comparing the UK Clinical Practice Research Datalink with a hospital-based cohort // Rheumatology (Oxford). 2017. Vol. 56, N 12. P. 2109-2113. doi: 10.1093/rheumatology/kex323

[7] Koreshkova KM, Khismatullina ZR. Quality of life in patients with psoriatic arthritis. Vestnik dermatologii i venerologii. 2021;97(3):56-65. EDN: EUORBI doi: 10.25208/vdv1213

[8] Корешкова К.М., Хисматуллина З.Р. Качество жизни у больных псориатическим артритом // Вестник дерматологии и венерологии. 2021. Т. 97, № 3. C. 56-65. EDN: EUORBI doi: 10.25208/vdv1213

[9] Martin BI, Deyo RA, Mirza SK, et al. Expenditures and health status among adults with back and neck problems. JAMA. 2008;299(6):656-664. doi: 10.1001/jama.299.6.656

[10] Martin B.I., Deyo R.A., Mirza S.K., et al. Expenditures and health status among adults with back and neck problems // JAMA. 2008. Vol. 299, N 6. P. 656-664. doi: 10.1001/jama.299.6.656

[11] Luo X, Pietrobon R, Sun SX, et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine (Phila Pa 1976). 2004;29(1):79-86. doi: 10.1097/01.BRS.0000105527.13866.0F

[12] Luo X., Pietrobon R., Sun S.X., et al. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States // Spine (Phila Pa 1976). 2004. Vol. 29, N 1. P. 79-86. doi: 10.1097/01.BRS.0000105527.13866.0F

[13] Loginova E, Korotaeva TV, Smirnov AV, et al. Specific features of axial skeleton involvement in early psoriatic arthritis (the REMARCA trial). Rheumatol Sci Pract. 2016;54(S1):15-19. EDN: WXHHHN doi: 10.14412/1995-4484-2016-1S-15-19

[14] Логинова Е.Ю., Коротаева Т.В., Смирнов А.В., и др. Особенности поражения осевого скелета при раннем псориатическом артрите (исследование РЕМАРКА) // Научно-практическая ревматология. 2016. Т. 54, № S1. С. 15-19. EDN: WXHHHN doi: 10.14412/1995-4484-2016-1S-15-19

[15] Belinchón I, Salgado-Boquete L, López-Ferrer A, et al. Dermatologists’ role in the early diagnosis of psoriatic arthritis: Expert recommendations. Actas Dermosifiliogr (Engl Ed). 2020;111(10):835-846. doi: 10.1016/j.ad.2020.06.004

[16] Belinchón I., Salgado-Boquete L., López-Ferrer A., et al. Dermatologists’ role in the early diagnosis of psoriatic arthritis: Expert recommendations // Actas Dermosifiliogr (Engl Ed). 2020. Vol. 111, N 10. P. 835-846. doi: 10.1016/j.ad.2020.06.004

[17] Chamurlieva MN, Loginova EY, Korotaeva TV. Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice. Modern Rheumatol J. 2019;13(4):48-54. EDN: MKVNBR doi: 10/14412/1996-7012-2019-4-48-54

[18] Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость периферических и аксиальных проявлений псориатического артрита у больных псориазом в дерматологической практике // Современная ревматология. 2019. Т. 13, № 4. С. 48-54. EDN: MKVNBR doi: 10/14412/1996-7012-2019-4-48-54

[19] Bagel J, Schwartzman S. Enthesitis and dactylitis in psoriatic disease: A guide for dermatologists. Am J Clin Dermatol. 2018;19(6):839-852. EDN: KVBAQO doi: 10.1007/s40257-018-0377-2

[20] Bagel J., Schwartzman S. Enthesitis and dactylitis in psoriatic disease: A guide for dermatologists // Am J Clin Dermatol. 2018. Vol. 19, N 6. P. 839-852. EDN: KVBAQO doi: 10.1007/s40257-018-0377-2

[21] Van der Heijde D, Ramiro S, Landewe R, et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis. Ann Rheum Dis. 2017;76(6):978-991. EDN: YDRYYK doi: 10.1136/annrheumdis-2016-210770

[22] Van der Heijde D., Ramiro S., Landewe R., et al. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis // Ann Rheum Dis. 2017. Vol. 76, N 6. P. 978-991. EDN: YDRYYK doi: 10.1136/annrheumdis-2016-210770

[23] Jadon D, Sengupta R, Nightingale A, et al. Axial disease in psoriatic arthritis study: Defining the clinical and radiographic phenotype of psoriatic spondyloarthritis. Ann Rheum Dis. 2017;76(4):701-707. doi: 10.1136/annrheumdis-2016-209853

[24] Jadon D., Sengupta R., Nightingale A., et al. Axial disease in psoriatic arthritis study: Defining the clinical and radiographic phenotype of psoriatic spondyloarthritis // Ann Rheum Dis. 2017. Vol. 76, N 4. P. 701-707. doi: 10.1136/annrheumdis-2016-209853

[25] Chamurlieva MN, Loginova EY, Korotaeva TV. Detection rates of psoriatic arthritis in patients with psoriasis in a dermatology and rheumatology clinic. Modern Rheumatol J. 2016;10(4):47-50. EDN: XEKFAH doi: 10.14412/1996-7012-2016-4-47-50

[26] Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость псориатического артрита у больных псориазом в дерматологической и ревматологической клинике // Современная ревматология. 2016. Т. 10, № 4. C. 47-50. EDN: XEKFAH doi: 10.14412/1996-7012-2016-4-47-50

[27] Chamurlieva MN, Loginova EY, Korotaeva TV. Detectability of the peripheral and axial manifestations of psoriatic arthritis in patients with psoriasis in dermatological practice. Modern Rheumatol J. 2019;13(4):48-54. EDN: MKVNBR doi: 10.14412/1996-7012-2019-4-48-54

[28] Чамурлиева М.Н., Логинова Е.Ю., Коротаева Т.В. Выявляемость периферических и аксиальных проявлений псориатического артрита у больных псориазом в дерматологической практике // Современная ревматология. 2019. Т. 13, № 4. С. 48-54. EDN: MKVNBR doi: 10.14412/1996-7012-2019-4-48-54

[29] Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol. 2010;37(4):809-815. doi: 10.3899/jrheum.091059

[30] Chandran V., Tolusso D.C., Cook R.J., Gladman D.D. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis // J Rheumatol. 2010. Vol. 37, N 4. P. 809-815. doi: 10.3899/jrheum.091059

[31] Chandran V, Barrett J, Schentag CT, et al. Axial psoriatic arthritis: Update on a longterm prospective study. J Rheumatol. 2009;36(12):2744-2750. doi: 10.3899/jrheum.090412

[32] Chandran V., Barrett J., Schentag C.T., et al. Axial psoriatic arthritis: Update on a longterm prospective study // J Rheumatol. 2009. Vol. 36, N 12. P. 2744-2750. doi: 10.3899/jrheum.090412

[33] Chyuan IT, Chen JY. Role of interleukin-(IL-) 17 in the pathogenesis and targeted therapies in spondyloarthropathies. Mediators Inflamm. 2018;2018:2403935. doi: 10.1155/2018/2403935

[34] Chyuan I.T., Chen J.Y. Role of interleukin-(IL-) 17 in the pathogenesis and targeted therapies in spondyloarthropathies // Mediators Inflamm. 2018. Vol. 2018. P. 2403935. doi: 10.1155/2018/2403935

[35] Lassiter W, Allam A. Inflammatory back pain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023.

[36] Lassiter W., Allam A. Inflammatory back pain. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023.

[37] Gladman DD, Brubacher B, Buskila D, et al. Differences in the expression of spondyloarthropathy: А comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med. 1993;(16):1-7.

[38] Gladman D.D., Brubacher B., Buskila D., et al. Differences in the expression of spondyloarthropathy: А comparison between ankylosing spondylitis and psoriatic arthritis // Clin Invest Med. 1993. N 16. P. 1-7.

[39] Hojgaard P, Ellegaard K, Nielsen SM, et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study. Arthritis Care Res (Hoboken). 2019;71(6):798-810. doi: 10.1002/acr.23693

[40] Hojgaard P., Ellegaard K., Nielsen S.M., et al. Pain mechanisms and ultrasonic inflammatory activity as prognostic factors in patients with psoriatic arthritis: A prospective cohort study // Arthritis Care Res (Hoboken). 2019. Vol. 71, N 6. P. 798-810. doi: 10.1002/acr.23693

[41] Weisman MH. Inflammatory back pain: The United States perspective. Rheum Dis Clin North Am. 2012;38(3):501-512. doi: 10.1016/j.rdc.2012.09.002

[42] Weisman M.H. Inflammatory back pain: The United States perspective // Rheum Dis Clin North Am. 2012. Vol. 38, N 3. P. 501-512. doi: 10.1016/j.rdc.2012.09.002

[43] Lindqvist U, Alenius GM, Husmark T, et al. The Swedish early psoriatic arthritis register: 2-years follow-up. A comparison with early rheumatoid arthritis. J Rheumatol. 2008;35(4):668-673.

[44] Lindqvist U., Alenius G.M., Husmark T., et al. The Swedish early psoriatic arthritis register: 2-years follow-up. A comparison with early rheumatoid arthritis // J Rheumatol. 2008. Vol. 35, N 4. P. 668-673.

[45] Gubar EE, Loginova EY, Smirnov AV, et al. Clinical and instrumental characteristics of axial lesion in early peripheral psoriatic arthritis (data of a REMARCA study). Rheumatol Sci Pract. 2018;56(1):34-40. EDN: XPLNML doi: 10.14412/1995-4484-2018-34-40

[46] Губарь Е.Е., Логинова Е.Ю., Смирнов А.В., и др. Клинико-инструментальная характеристика аксиального поражения при раннем периферическом псориатическом артрите (данные исследования РЕМАРКА) // Научно-практическая ревматология. 2018. Т. 56, № 1. С. 34-40. EDN: XPLNML doi: 10.14412/1995-4484-2018-34-40

[47] Dillon CF, Hirsch R. The United States national health and nutrition examination survey and the epidemiology of ankylosing spondylitis. Am J Med Sci. 2011;341(4):281-283. doi: 10.1097/MAJ.0b013e31820f8c83

[48] Dillon C.F., Hirsch R. The United States national health and nutrition examination survey and the epidemiology of ankylosing spondylitis // Am J Med Sci. 2011. Vol. 341, N 4. P. 281-283. doi: 10.1097/MAJ.0b013e31820f8c83

[49] Chandran V. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: Same or different? Curr Opinion Rheumatol. 2019;31(4):329-334. doi: 10.1097/BOR.0000000000000609

[50] Chandran V. Psoriatic spondylitis or ankylosing spondylitis with psoriasis: Same or different? // Curr Opinion Rheumatol. 2019. Vol. 31, N 4. P. 329-334. doi: 10.1097/BOR.0000000000000609

RIGHTS & PERMISSIONS

Eco-Vector